Advanced Therapies Europe 2025 Debuts Curated 500-Attendee Format
Advanced Therapies Europe arrives in Barcelona for the first time, taking place from 2-4 September 2025 at the Hotel Arts, Ritz-Carlton. With a bold new focus, this year’s edition...
Category : Healthcare and Pharmaceutical
Caris Life Sciences Raises $168M to Expand Precision Platform
Caris Life Sciences® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer, announced today that the company has closed a growth capital funding round...
ABL Bio Licenses Grabody-B Platform to GSK for Brain Drugs
ABL Bio and GSK enter into a multi-program agreement to develop novel medicines for neurodegenerative diseases Programs will leverage ABL Bio’s Grabody-B platform technology to effectively deliver molecules across...
Alcanza Clinical Research Adds New President and CFO
Alcanza Clinical Research, a mission-focused investigator site network dedicated to reducing barriers to clinical research participation, announces the appointment of Karim Chalhoub as President and Chief Operating...
FTI Consulting Expands Healthcare Team in Australia with 7 Hires
Six Senior Managing Directors and a Managing Director Build on February’s Practice Launch FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of six Senior...
Scale Bio Joins CZI’s Billion Cells Project to Advance Single Cell Research
Scale Bio’s QuantumScale Single Cell RNA Kits Are Now Available for Order to Commercial and Academic Customers, Enabling the Analysis of Millions of Cells in...
ABEC Launches Advanced Single-Use Bioreactor for Cell Therapy
ABEC, a global leader in engineered solutions and services for biotech manufacturing, has introduced its Advanced Therapy Bioreactor (ATB™) – a revolutionary platform poised to...
BeiGene Ends Ociperlimab Clinical Program Following Futility Analysis
BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced the...
restor3d Raises $38M to Expand Personalized Orthopedic Solutions
restor3d, a leader in 3D printed, personalized orthopedic implant care, announced today the successful completion of capital raising efforts totaling $38 million. These funding rounds...
ENHERTU® EU Approval: First HER2 Therapy for HR+ Metastatic BC
Daiichi Sankyo (TSE: 4568) and AstraZeneca’s (LSE/STO/Nasdaq: AZN) ENHERTU® (trastuzumab deruxtecan) has been approved in the European Union (EU) as a monotherapy for the treatment of...
MOASC Honors Young Investigator, Advancing Oncology Research
Dr. Peter Zang receives the 2025 Cary Presant, MD Young Investigator Award for his groundbreaking research on metastatic castrate-resistant prostate cancer, improving treatment strategies and patient outcomes....
Carrum Health Expands COE Network, Reaching 90% of Americans
Carrum scales its value-based COE model by tailoring it for each specialty, expanding to 1,000+ locations and managing 40% of employer medical spend Today, Carrum Health,...
AscellaHealth Q1 2025 Specialty & Rare Pipeline Digest™
AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, today unveiled its latest Specialty & Rare Pipeline Digest™, the industry’s most comprehensive digital...
Aclarion Expands to Santa Monica with MICSC
MICSC are leaders in Los Angeles providing MRI and Diagnostic Imaging services MICSC expands access to Nociscan beyond Beverly Hills now available in Santa Monica...
Boehringer Ingelheim Expands ADC Portfolio with Basel R&D Center
Today NBE Therapeutics (NBE) a wholly owned subsidiary of Boehringer Ingelheim, officially opened its new ADC R&D facility in Basel. This milestone reinforces its commitment to innovation in oncology and strengthens its footprint in Switzerland’s biotech ecosystem. NBE Therapeutics, a Swiss biotech founded in 2012 that...